Page last updated: 2024-11-05

troglitazone and Carotid Artery Diseases

troglitazone has been researched along with Carotid Artery Diseases in 2 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Carotid Artery Diseases: Pathological conditions involving the CAROTID ARTERIES, including the common, internal, and external carotid arteries. ATHEROSCLEROSIS and TRAUMA are relatively frequent causes of carotid artery pathology.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zheng, L1
Hodis, HN2
Buchanan, TA2
Li, Y1
Mack, WJ1
Xiang, AH1
Kawakubo, M1
Peters, RK1
Kjos, SL1
Marroquin, A1
Goico, J1
Ochoa, C1
Liu, CR1
Liu, CH1

Trials

2 trials available for troglitazone and Carotid Artery Diseases

ArticleYear
Effect of antihypertensive therapy on progression of carotid intima-media thickness in patients with type 2 diabetes mellitus.
    The American journal of cardiology, 2007, Apr-01, Volume: 99, Issue:7

    Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Carotid Artery Diseases; Carotid Artery, Commo

2007
Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes.
    Atherosclerosis, 2008, Volume: 199, Issue:1

    Topics: Adult; Carotid Artery Diseases; Chromans; Diabetes Mellitus, Type 2; Diabetes, Gestational; Disease

2008